NIRAMAI: A Novel A.I.- based Breast Cancer Screening solution

 Gaurang ,

 

This is in context of my telecom this evening,

 

I am glad that you have already started collecting expert opinions re the efficacy of NIRAMAI’s thermal imaging technology

 

By a copy of this mail, I am asking Darshan to :

 

#   Call up Kamal Valecha ( who is based in Ahmedabad ) , meet him and understand the nitty-gritty of this technology ( Kamal is willing to visit you / your team in Rajkot for a presentation )

 

#  Inquire with CIMS hospital where NIRAMAI claim to have installed this system ( SSG hospital – Vadodara also have this system for sometime now )

 

I am sure Kamal will provide the names / phone numbers of doctors at both these hospitals who are using this device

 

Kamal did mention that the imported thermal-imaging machine  ( Swiss ? ) costs around Rs 10 lakhs ( ball park figure )

 

As far as ANALYTICS SOFTWARE is concerned , I vaguely understood that NIRAMAI do NOT charge any amount up-front but hospital pays – per – use ( Rs 600 / report )

 

Regards,

 

Batuk Kaka

 

Darshan :

 

I will phone you re background

 

From: Kamal Valecha [mailto:kamal.valecha@niramai.com]
Sent: 04 August 2022 14:57
To: Hemen Parekh
Cc: Surajit Mukherjee; Dr. Geetha Manjunath
Subject: NIRAMAI: A Novel A.I.- based Breast Cancer Screening solution

 

Dear Hemen Parekh Sir,

Greetings from NIRAMAI !

Thank you for your interest in newer technologies that are helping society in decreasing the cancer burden. We truly echo your thoughts on preventive healthcare, wellness, and early detection of cancer.

 

Sir, as discussed, sharing a brief note about Niramai's breakthrough below:

Niramai’s unique and clinically proven Thermalytix solution involves a ‘No Touch’, ‘No See’, ‘No Radiation’ and ‘No Pain’ approach and is already approved by DCGI/CDSCO and has also received the European CE and ISO 13485 certification. We have completed 55,000+ screenings and are present in 110+ centres across 25 Indian cities including Apollo Clinics, Apollo Spectra, HCG Hospitals, Rainbow Children Hospitals, Marengo CIMS Hospital, and Medall Diagnostics amongst others. This unique solution has been developed by Dr. Geetha Manjunath - PhD in Artificial Intelligence from IISc Bangalore.
You will be pleased to know that the Government of Punjab has contracted Niramai for conducting state-wide screenings from June 15, 2022.

Sharing the following files for your quick reference: (A) Clinical Brochure, (B) Company Profile and (C) Screening Flyer. Sir, as discussed, there exists a wonderful opportunity for your network and Niramai to work together for the early detection of breast cancer in the community. We will wait for your kind revert for the next steps. .
Thanks & Regards Kamal Valecha

Sr. Manager, Business Development
M: 9512749495
https://www.niramai.com

CONFIDENTIALITY NOTICE: The contents of this email message and any attachments are intended solely for the addressee(s) and may contain confidential and/or privileged information and may be legally protected from disclosure. If you are not the intended recipient of this message or their agent, or if this message has been addressed to you in error, please immediately alert the sender by reply email and then delete this message and any attachments. If you are not the intended recipient, you are hereby notified that any use, dissemination, copying, or storage of this message or its attachments is strictly prohibited.